Recent developments in the immunopathology of COVID‐19
There has been an important change in the clinical characteristics and immune profile of
Coronavirus disease 2019 (COVID‐19) patients during the pandemic thanks to the …
Coronavirus disease 2019 (COVID‐19) patients during the pandemic thanks to the …
Therapeutic effects of inhaled nitric oxide therapy in COVID-19 patients
The global COVID-19 pandemic has become the largest public health challenge of recent
years. The incidence of COVID-19-related acute hypoxemic respiratory failure (AHRF) …
years. The incidence of COVID-19-related acute hypoxemic respiratory failure (AHRF) …
Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts
Background Patients with COVID-19-related acute respiratory distress syndrome (ARDS)
have been postulated to present with distinct respiratory subphenotypes. However, most …
have been postulated to present with distinct respiratory subphenotypes. However, most …
Real world evidence of calcifediol or vitamin D prescription and mortality rate of COVID-19 in a retrospective cohort of hospitalized Andalusian patients
COVID-19 is a major worldwide health problem because of acute respiratory distress
syndrome, and mortality. Several lines of evidence have suggested a relationship between …
syndrome, and mortality. Several lines of evidence have suggested a relationship between …
Risking further COVID-19 waves despite vaccination
The sudden outbreak and global spread of COVID-19 took the world by surprise. Policy
makers started to work side-by-side with theoreticians, as there were and still are many …
makers started to work side-by-side with theoreticians, as there were and still are many …
Casirivimab+ imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles
Severe, protracted symptoms are associated with poor outcomes in severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection. In a placebo-controlled study of …
syndrome coronavirus 2 (SARS-CoV-2) infection. In a placebo-controlled study of …
Long-term impact of COVID-19 associated acute respiratory distress syndrome
J Aranda, I Oriol, M Martín, L Feria, N Vázquez… - Journal of Infection, 2021 - Elsevier
Objectives To determine the health status, exercise capacity, and health related quality of life
(HRQoL) of COVID-19 associated acute respiratory distress syndrome (ARDS) survivors, 8 …
(HRQoL) of COVID-19 associated acute respiratory distress syndrome (ARDS) survivors, 8 …
Clinical sepsis phenotypes in critically ill patients
G Papathanakos, I Andrianopoulos, M Xenikakis… - Microorganisms, 2023 - mdpi.com
Sepsis, defined as the life-threatening dysregulated host response to an infection leading to
organ dysfunction, is considered as one of the leading causes of mortality worldwide …
organ dysfunction, is considered as one of the leading causes of mortality worldwide …
Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort …
G Moreno, R Carbonell, I Martin-Loeches… - Annals of Intensive …, 2021 - Springer
Background Some unanswered questions persist regarding the effectiveness of
corticosteroids for severe coronavirus disease 2019 (COVID-19) patients. We aimed to …
corticosteroids for severe coronavirus disease 2019 (COVID-19) patients. We aimed to …
Cardiovascular biomarkers for prediction of in-hospital and 1-year post-discharge mortality in patients with COVID-19 pneumonia
LJ Motloch, P Jirak, D Gareeva, P Davtyan… - Frontiers in …, 2022 - frontiersin.org
Aims While COVID-19 affects the cardiovascular system, the potential clinical impact of
cardiovascular biomarkers on predicting outcomes in COVID-19 patients is still unknown …
cardiovascular biomarkers on predicting outcomes in COVID-19 patients is still unknown …